Retigabine
CAS: 150812-12-7
Ref. 3D-FA61501
1g | 352,00 € | ||
2g | 499,00 € | ||
100mg | 118,00 € | ||
250mg | 196,00 € | ||
500mg | 264,00 € |
Información del producto
- 2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene
- 2-Amino-4-(4-Fluorbenzylamino)-1-Ethoxycarbonylaminobenzene
- Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- D 23129
- D2312
- Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
- Ethyl {2-Amino-4-[(4-Fluorobenzyl)Amino]Phenyl}Carbamate
- Ezogabine
- Gke 841
- Ver más sinónimos
- Gw 582892X
- N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester
- Potiga
- Retigabin
- RetigabineDiscontinued See: R189051
- Trobalt
- Way 143841
- [2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
Retigabine is a carbamate that binds to the benzodiazepine binding site of the gamma-aminobutyric acid receptor. It has been shown to have analgesic properties in animal studies, and has also been investigated as a potential treatment for epilepsy. Retigabine may be used in combination with other drugs, such as flumazenil, which can reverse its effects. The structural analog of retigabine is flumazenil, a drug that can reverse the effects of benzodiazepines such as diazepam and midazolam. Retigabine also interacts with other drugs through significant effects on their pharmacokinetics and pharmacodynamics.
Propiedades químicas
Consulta técnica sobre: 3D-FA61501 Retigabine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.